NASHVILLE, Tenn.–(BUSINESS WIRE)–SUPERWISE®, a leader in enterprise AI governance and observability, has announced a strategic partnership with NuevoSono, a company focused on revolutionizing intravascular ultrasound (IVUS) technology. This collaboration integrates trusted, explainable AI into NuevoSono’s next-generation IVUS platform, which aims to be the highest-resolution ultrasound system for detecting coronary plaques and assessing lesions, enhancing clinical workflow without the need for significant capital equipment investment.
“From the start, making AI accessible to companies that improve lives has been central to our mission,” said Russ Blattner, CEO of SUPERWISE. “We’re excited to deliver high-quality computer vision models and our Enterprise AI Governance and Operations platform to NuevoSono.”
Coronary Artery Disease (CAD) continues to be a leading cause of mortality globally, making accurate assessment of arterial plaque critical for effective treatment decisions. NuevoSono’s IVUS technology, utilizing broadband frequency, is designed to deliver high-resolution imaging that offers detailed visualization of coronary anatomy. The integration of AI into this platform is expected to enhance consistency in image interpretation, streamline clinical workflows, and support clinical decision-making aligned with intervention outcomes.
The push for AI adoption in medical imaging is gaining momentum as healthcare systems strive for greater diagnostic consistency and operational efficiency. According to a report by Gartner, Inc. titled “Innovation Insight: AI-Enabled Medical Image Interpretation” published in March 2025, healthcare provider CIOs and leaders in medical imaging have shown increasing interest in leveraging AI technologies. Key motivators include improved diagnostic accuracy, enhanced operational efficiency, and a reduction in clinician burnout.
“AI is an important component of our next-generation IVUS platform, but accuracy alone is not sufficient,” stated Marwan Berrada, founder and interim CEO of NuevoSono. “The models we deploy must be secure, compliant, and clinically reliable. Partnering with SUPERWISE allows us to integrate AI responsibly as we advance the platform toward clinical use.”
NuevoSono’s IVUS platform is currently in development, with the company gearing up for commercialization as it progresses toward the introduction of a system capable of exceptionally high imaging resolution for coronary plaque assessment. This development aligns with the increasing demand for advanced imaging solutions in clinical environments.
As AI technology continues to evolve, the implications for healthcare are profound. The integration of intelligent systems like those being developed by SUPERWISE and NuevoSono promises to not only enhance diagnostic capabilities but also improve patient outcomes through more informed clinical decisions. The future of intravascular imaging appears poised for considerable transformation as these advancements unfold.
About SUPERWISE®
SUPERWISE is an Enterprise AI Agentic Governance and Operations Platform designed for real-world deployment. It combines AI observability, risk management, and operational oversight into a unified solution, ensuring AI remains powerful, trusted, and aligned with organizational goals. The platform’s built-in guardrails, explainability, and compliance features empower teams across regulated sectors, such as healthcare and finance, to achieve robust AI performance at scale.
About NuevoSono
NuevoSono, a portfolio company of T45 Labs, is developing a next-generation IVUS platform that aims to facilitate everyday clinical use by addressing barriers that have historically limited broader adoption of such technologies. The system is designed to deliver high-definition imaging with a compact, plug-and-play format that integrates seamlessly into existing cath lab workflows. Based in Silicon Valley, the team brings a wealth of experience in medical imaging, device engineering, and clinical development, aiming for first-in-human studies planned for 2025.
Media Contact:
Jo Ann M Stadtmueller
[email protected]
OpenAI’s Rogue AI Safeguards: Decoding the 2025 Safety Revolution
US AI Developments in 2025 Set Stage for 2026 Compliance Challenges and Strategies
Trump Drafts Executive Order to Block State AI Regulations, Centralizing Authority Under Federal Control
California Court Rules AI Misuse Heightens Lawyer’s Responsibilities in Noland Case
Policymakers Urged to Establish Comprehensive Regulations for AI in Mental Health
